Objectives:
- Review recent data on the efficacy of pre-exposure prophylaxis (PrEP), particularly in teens and younger adults
- Cite the results of two clinical trials of new antiretroviral agents
- Discuss recent findings with two drug ART regimens for ongoing viral suppression
Session date:
11/13/2017 - 12:00pm to 1:00pm CST
Location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Resnlow Sherer, MD